234win bet login

In a landmark case that has drawn widespread attention across Spain, four men were convicted on Sunday for their roles in the homophobic murder of Samuel Luiz, a 24-year-old nursing assistant. The conviction comes after the brutal assault outside a nightclub in A Coruna in July 2021, which led to nationwide protests against hate crimes. The accused, Diego Montaña, Alejandro Freire, and Kaio Amaral, were found guilty of aggravated murder. Montaña, identified as the ringleader, mistakenly believed Luiz to be gay due to his mannerisms and clothing, hurling homophobic slurs before and after the attack. Meanwhile, Alejandro Míguez was convicted of complicity. The jury's verdict followed an intensive deliberation spanning five days after a trial lasting nearly a month. Sentencing is forthcoming, with the prosecution seeking prison terms ranging from 22 to 27 years. The case highlights broader issues as recent data from Spain's Interior Ministry reports 364 hate crimes related to sexual orientation in 2023, reflecting persistent challenges in addressing such offenses. (With inputs from agencies.)

NEW YORK (AP) — Shohei Ohtani wins his third MVP and first in the NL following a historic offensive season with the Los Angeles Dodgers.( MENAFN - Newsfile Corp) New York, New York--(Newsfile Corp. - December 22, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") in connection with the Company's April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the "Class Period"); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's September 2024 secondary public offering ("SPO"), of the important January 13, 2025 lead plaintiff deadline . SO WHAT: If you purchased PACS common stock pursuant and/or traceable to the IPO and/or securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the PACS class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email ... for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, in the Registration Statement and throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) PACS engaged in a "scheme" to submit false Medicare claims which "drove more than 100% of PACS' operating and net income from 2020 - 2023"; (2) PACS engaged in a "scheme" to "bill thousands of unnecessary respiratory and sensory integration therapies to Medicare"; (3) PACS engaged in a scheme to falsify documentation related to licensure and staffing; and (4) as a result of the foregoing, defendants' positive statements about PACS' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the PACS class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email ... for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: , on Twitter: or on Facebook: . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 ... To view the source version of this press release, please visit SOURCE: The Rosen Law Firm PA MENAFN22122024004218003983ID1109021839 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Freeland says the two-month GST holiday is meant to tackle the 'vibecession'Stocks to Watch: Vedanta, NHPC, Reliance Industries, and more